Genomics

Dataset Information

0

JMJD6 gene gain is a tumorigenic factor and therapeutic target in neuroblastoma

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE113140 | GEO | 2019/06/23

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Unknown JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma.
| S-EPMC6658504 | biostudies-literature
Genomics JMJD6 gene gain is a tumorigenic factor and therapeutic target in neuroblastoma
| PRJNA450133 | ENA
Transcriptomics DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
2022-07-27 | GSE209813 | GEO
Transcriptomics Pre-clinical spheroid models identify BMX as a therapeutic target for metastatic MYCN non-amplified neuroblastoma
2024-06-30 | GSE223902 | GEO
Transcriptomics HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration
2014-10-10 | E-GEOD-38237 | biostudies-arrayexpress
Genomics The transcriptional factor ONECUT3 is a driver and therapeutic target for complex karyotype MDS
2024-03-01 | GSE202694 | GEO
Transcriptomics A critical role of microRNAs in human pulmonary arterial hypertension. miR-204: a novel therapeutic target
2010-12-16 | E-GEOD-21284 | biostudies-arrayexpress
Transcriptomics The histone H3 lysine 4 presenter WDR5 induces N-Myc target gene transcription and promotes neuroblastoma
2015-12-31 | E-GEOD-70099 | biostudies-arrayexpress
Transcriptomics Gene Body Methylation Directly Increases Gene Expression and is a Therapeutic Target for Genes Upregulated in Cancer
2014-08-01 | E-GEOD-51815 | biostudies-arrayexpress
Transcriptomics Early epigenomic and transcriptional changes reveal Elk-1 transcription factor as a therapeutic target in Huntington’s disease
2019-11-19 | GSE140118 | GEO